Derivatives of structurally modified vip and pharmaceutical compositions containing them

作者: Illana Gozes , Matityahu Fridkin

DOI:

关键词:

摘要: There are provided novel compounds for the treatment of male impotence. The derived from vasoactive intestinal peptide (VIP) in which natural amino acid sequence is modified by replacement any 5, 17 and 19 residues other or non-natural acids, they bear at least one terminal lipophilic group. VIP sequences prepared conventional chain assembling methods. compositions containing them suitable transdermal application treating

参考文章(21)
Viktor Mutt, Ann Nilsson, Sami I. Said, Vasoactive intestinal peptide from fowl ,(1975)
Robert P. Giannini, Charles R. Daniels, Pramod P. Sarpotdar, James L. Gaskill, L-α-amino acids as transdermal penetration enhancers ,(1985)
Miklos Bodanszky, Cynthia Yang Lin, Sami I. Said, The vasoactive intestinal peptide (VIP): VI. The 17-norleucine analog of the sequence 14–28☆ Bioorganic Chemistry. ,vol. 3, pp. 320- 323 ,(1974) , 10.1016/0045-2068(74)90021-2
David R. Bolin, Iou-Iou Sytwu, Johannes A. Meienhofer, Synthetic vasoactive intestinal peptide analogs ,(1986)
Shinro Tachibana, Osamu Ito, Physiologically active peptide ,(1987)
G. Wagner, T. Gerstenberg, Intracavernosal injection of vasoactive intestinal polypeptide (VIP) does not induce erection in man per se World Journal of Urology. ,vol. 5, pp. 171- 172 ,(1987) , 10.1007/BF00326826
Haim Werner, Yitzhak Koch, Mati Fridkin, Jan Fahrenkrug, Illana Gozes, High levels of vasoactive intestinal peptide in human milk Biochemical and Biophysical Research Communications. ,vol. 133, pp. 228- 232 ,(1985) , 10.1016/0006-291X(85)91865-0